Molecular Biology Terms Starting With A

Alternative Splicing is the process by which different combinations of exons from a single pre-mRNA are joined to produce multiple distinct mRNA isoforms that encode different protein variants.

The major modes of alternative splicing include exon skipping, alternative 5-prime or 3-prime splice site selection, intron retention, and mutually exclusive exon use. Over 90 percent of human multi-exon genes undergo alternative splicing, dramatically expanding the protein repertoire beyond what gene number alone would predict. Tissue-specific splicing regulators including SR proteins and hnRNPs control which exons are included or excluded in different cell types and developmental stages.

Disruption of these regulatory decisions contributes to dozens of human diseases, including spinal muscular atrophy, where a splicing defect in the SMN2 gene reduces production of functional SMN protein.

Amplicon is the specific DNA or RNA fragment produced by amplification, particularly the product generated by PCR that spans the region between two primer binding sites.

Amplicon size is determined by the positions of the forward and reverse primers and is a key parameter in PCR design, with shorter amplicons typically amplifying more efficiently than longer ones. In diagnostic PCR, the identity of an amplicon is confirmed by its size on an agarose gel, and its sequence or restriction pattern provides additional specificity. Next-generation sequencing of amplicons generated from many genomic loci simultaneously, called amplicon sequencing, is used for targeted variant detection in clinical diagnostics.

Amplicons as short as 60 to 80 base pairs are preferred when working with degraded DNA, such as samples extracted from formalin-fixed tissue.

Amyloid is an abnormal protein aggregate formed when proteins misfold and stack into long, rigid cross-beta fibers that accumulate in tissues and are associated with diseases including Alzheimer's disease, type 2 diabetes, and systemic amyloidosis.

Normally, proteins fold into precise three-dimensional shapes dictated by their amino acid sequences. Through mutation, aging, or cellular stress, certain proteins adopt alternative conformations that expose hydrophobic surfaces, driving self-association into oligomers and then into insoluble fibrils. These fibrils share a characteristic cross-beta sheet architecture in which beta strands run perpendicular to the fibril axis, a structure that resists proteolytic degradation and accumulates over years.

In Alzheimer’s disease, amyloid-beta peptides derived from cleavage of amyloid precursor protein aggregate into plaques between neurons, while tau protein forms intracellular tangles through a related but distinct aggregation mechanism.

Annealing is the process by which complementary single-stranded nucleic acid sequences come together through hydrogen bonding between complementary base pairs to form a stable double-stranded structure.

In PCR, the annealing step involves cooling the reaction to allow primers to bind their complementary sequences on denatured template DNA. Typical annealing temperatures range from 50 to 65 degrees Celsius and are usually set 5 degrees below the melting temperature of the primers to maximize specificity while maintaining efficient primer binding. Annealing underlies many molecular biology techniques including Southern blotting, northern blotting, in situ hybridization, and microarray analysis.

Setting the annealing temperature too low increases the risk of nonspecific amplification, while too high a temperature reduces yield by preventing stable primer binding.

Aptamer is a short single-stranded DNA or RNA oligonucleotide that folds into a specific three-dimensional structure enabling it to bind a target molecule with high affinity and selectivity, analogous to an antibody.

Aptamers are identified through systematic evolution of ligands by exponential enrichment, a selection process that screens libraries of up to 10 to the 15th power random sequences for molecules that bind a chosen target. Their binding affinity to diverse targets including proteins, small molecules, and even whole cells rivals that of monoclonal antibodies, with dissociation constants often in the nanomolar to picomolar range. Pegaptanib, an RNA aptamer targeting vascular endothelial growth factor, was the first FDA-approved aptamer therapeutic, cleared in 2004 to treat neovascular age-related macular degeneration.

Unlike antibodies, aptamers can be chemically synthesized without cell culture, stored at room temperature when lyophilized, and modified with chemical groups to extend their half-life in blood.

Argonaute is a protein that forms the catalytic core of the RNA-induced silencing complex, binding small RNA guides such as siRNA or microRNA and using them to locate and silence complementary messenger RNA targets through cleavage or translational repression.

Argonaute proteins share two conserved domains central to their function: the PAZ domain, which anchors the 3-prime end of the guide RNA, and the PIWI domain, which adopts an RNase H-like fold and carries out mRNA cleavage when guide-target complementarity is sufficient. Humans encode four Argonaute proteins, designated AGO1 through AGO4, of which only AGO2 retains catalytic slicer activity. When a loaded Argonaute encounters an mRNA with perfect or near-perfect complementarity to its guide, AGO2 cleaves the target between nucleotides 10 and 11 of the guide sequence.

Partial complementarity, typical of most microRNA-target interactions in animals, instead leads to translational repression and mRNA destabilization without direct cleavage.

Aryl Hydrocarbon Receptor is a ligand-activated transcription factor that, upon binding planar aromatic compounds such as dioxins, polycyclic aromatic hydrocarbons, or endogenous metabolites, translocates to the nucleus and drives expression of genes involved in xenobiotic metabolism and immune regulation.

The receptor normally resides in the cytoplasm bound to a chaperone complex that keeps it inactive. When a lipophilic ligand diffuses across the plasma membrane and binds the receptor’s ligand-binding domain, the chaperone complex dissociates, and the receptor translocates to the nucleus, where it dimerizes with ARNT and binds xenobiotic response elements upstream of target genes. Primary targets include CYP1A1, CYP1A2, and CYP1B1, cytochrome P450 enzymes that oxidize aromatic compounds to facilitate their excretion.

Persistent activation by dioxins and related halogenated compounds, which resist metabolism and accumulate in fat tissue, can cause chloracne, developmental toxicity, and increased cancer risk by sustaining transcriptional programs beyond their normal duration.

Assembly Factor is a protein that facilitates the correct assembly of a multi-subunit macromolecular complex but is not itself a component of the final mature complex, functioning as a dedicated chaperone for the construction process.

Assembly factors for ribosomes, spliceosomes, proteasomes, and mitochondrial respiratory chain complexes ensure that subunits fold correctly and join in the proper order, often preventing premature or incorrect interactions. Many assembly factors are ATPases or GTPases that use nucleotide hydrolysis to provide directionality and quality control during the process. Ribosome biogenesis alone requires more than 200 dedicated assembly factors in eukaryotes, most of which associate transiently with pre-ribosomal particles in the nucleolus before being released as the mature subunit exits to the cytoplasm.

Mutations in assembly factors cause a range of human diseases, reflecting how precisely coordinated macromolecular construction must be for normal cell function.